Skip to main content

Adjuvant Advanced Cervical Cancer GY037

A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

J Alex Garcia-Young, M.D., DABR
J Alex Garcia-Young, M.D., DABR
Principal investigator
View profile

Related studies

View all studies

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?